Virtus LifeSci Biotech Clinical Trials ETF
10 hedge funds and large institutions have $8.57M invested in Virtus LifeSci Biotech Clinical Trials ETF in 2015 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 2 increasing their positions, reducing their positions, and 2 closing their positions.
Holders
10
Holders Change
+6
Holders Change %
+150%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
2
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
1
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$0 |
| 2 |
VKH
2
Virtu KCG Holdings
New York
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Goldman Sachs
New York
| $6.57M | 200,000 | +200,000 | New |
|
2
LPL Financial
San Diego,
California
| $624K | 19,020 | +19,020 | New |
|
3
Jane Street
New York
| $565K | 17,217 | +4,459 | +35% |
|
|
CS
4
Credit Suisse
Zurich,
Switzerland
| $469K | 14,272 | +14,272 | New |
|
|
BAAM
5
Baker Avenue Asset Management
San Francisco,
California
| $267K | 8,120 | +8,120 | New |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $52K | 1,570 | +1,540 | +5,133% |
|
|
MPWT
7
MassMutual Private Wealth & Trust
Windsor,
Connecticut
| $8.14K | 248 | +248 | New |
|
8
UBS Group
Zurich,
Switzerland
| $8K | 234 | +234 | New |
|
9
Creative Planning
Overland Park,
Kansas
| $7K | 200 | +200 | New |
|
10
Morgan Stanley
New York
| $5K | 170 | +170 | New |
|
|
11
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | – | -224,754 | Closed |
|
|
VKH
12
Virtu KCG Holdings
New York
| – | – | -41,727 | Closed |
|